Progress in Treating Youth Smoking: Imperative, Difficult, Slow
Mené aux Etats-Unis sur la période 2012-2017 auprès de 157 adolescents fumeurs (âge médian : 19,1 ans), cet essai randomisé évalue l'efficacité du tartrate de varénicline, en complément de conseils hebdomadaires, pour arrêter de fumer
In this issue of JAMA Pediatrics, the article by Gray and colleagues addresses a critical public health question: How can we help adolescents and young adults quit smoking before they incur its full human and economic costs? Adolescent and young adult smokers are a critical population, given the substantial benefits of quitting smoking in young adulthood to avoid premature tobacco-related mortality; early cessation substantially reduces the risk of developing smoking-attributable disease. Although multiple smoking cessation treatments are effective for adults, improved effectiveness of smoking treatments for younger smokers is needed. Thus, this study addresses a huge, unmet public health need.
JAMA Pediatrics , éditorial, 2018